BioAmber strengthens board of directors
Ms. Richstone was the Chief Financial Officer of several public and private companies between 1989 and 2012, including Rohr Aerospace (a Fortune 500 Company). From 2002 to 2004, Ms. Richstone served as President and Chief Executive Officer of the Entrepreneurial Resources Group. From 2004 until its sale in 2007, she was the financial expert on the board of directors of American Power Conversion.
Currently, she serves on the corporate advisory boards of Paxeramed, a medical device company, and Pro Teck Valuation Services, and on the boards of non-profit organizations Employment Resources Inc. and the National Association of Corporate Directors-New England. In April 2013, Ms. Richstone was the recipient of the first annual Distinguished Director Award from the Corporate Directors Group.
Ms. Richstone graduated from Scripps College in Claremont California and holds graduate degrees from the Fletcher School of Law and Diplomacy at Tufts University. She also completed the Advanced Professional Certificate in Finance at New York University's Graduate School of Business Administration and attended the Executive Development program at Cornell University's Business School. She holds an Executive Master's Certification in Director Governance from the American College of Corporate Directors.
Mr. Linsert was the Chairman of the Board and Chief Executive Officer of Martek Biosciences Corporation from 1989 to 2006. Mr. Linsert subsequently founded Columbia Biosciences Corporation, a developer and manufacturer of fluorescent proteins, antibody conjugates and protein purification ligands, in 2007.
Prior to Martek, Mr. Linsert held several leadership positions in venture capital and investment firms. He also served as Captain in the United States Marine Corps. ■